Combination versus successive single agent chemotherapy in lymphocytic lymphoma
نویسندگان
چکیده
منابع مشابه
Introduction. Single-agent or combination chemotherapy in metastatic breast cancer.
It is fair to say that combination chemotherapy is the standard of care in metastatic breast cancer. In many ways, however, the burden of proof that it is the standard of care remains with those who advocate combination therapy. Some of the push to consider combination therapy as the standard is provided by a meta-analysis of trials comparing single-agent and combination therapy in this setting...
متن کاملSingle-Agent or Combination Chemotherapy in Metastatic Breast Cancer
It is fair to say that combination chemotherapy is the standard of care in metastatic breast cancer. In many ways, however, the burden of proof that it is the standard of care remains with those who advocate combination therapy. Some of the push to consider combination therapy as the standard is provided by a meta-analysis of trials comparing single-agent and combination therapy in this setting...
متن کاملCombination Chemotherapy of Advanced Chronic Lymphocytic Leukemia
1 1 10 Blood. Vol. 60. No. 5 (November). 1982 The M-2 protocol (vincristine. cyclophosphamide. BCNU. melphalan. and prednisone) was administered monthly to 63 evaluable patients with advanced chronic lymphocytic leukemia. Complete remission (absence of all clinical and bone marrow evidence of leukemia) and partial response (>50% decrease in organ enlargement and reduction of WBC count to below ...
متن کاملCombination Chemotherapy of Advanced Chronic Lymphocytic Leukemia : The M -
1 1 10 Blood. Vol. 60. No. 5 (November). 1982 The M-2 protocol (vincristine. cyclophosphamide. BCNU. melphalan. and prednisone) was administered monthly to 63 evaluable patients with advanced chronic lymphocytic leukemia. Complete remission (absence of all clinical and bone marrow evidence of leukemia) and partial response (>50% decrease in organ enlargement and reduction of WBC count to below ...
متن کاملCombination Chemotherapy of Advanced Chronic Lymphocytic Leukemia : The M - 2
1 1 10 Blood. Vol. 60. No. 5 (November). 1982 The M-2 protocol (vincristine. cyclophosphamide. BCNU. melphalan. and prednisone) was administered monthly to 63 evaluable patients with advanced chronic lymphocytic leukemia. Complete remission (absence of all clinical and bone marrow evidence of leukemia) and partial response (>50% decrease in organ enlargement and reduction of WBC count to below ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer
سال: 1978
ISSN: 0008-543X,1097-0142
DOI: 10.1002/1097-0142(197801)41:1<23::aid-cncr2820410106>3.0.co;2-y